Chemical Effects in Biological Systems (CEBS) object model for toxicology data, SysTox-OM: design and application

Science Applications International Corporation, 20201 Century Boulevard, 3rd Floor, Germantown, MD 20874, USA.
Bioinformatics (Impact Factor: 4.98). 05/2006; 22(7):874-82. DOI: 10.1093/bioinformatics/btk045
Source: DBLP


Motivation: The CEBS data repository is being developed to promote a systems biology approach to understand the biological effects of environmental stressors. CEBS will house data from multiple gene expression platforms (transcriptomics), protein expression and protein-protein interaction (proteomics), and changes in low molecular weight metabolite levels (metabolomics) aligned by their detailed toxicological context. The system will accommodate extensive complex querying in a user-friendly manner. CEBS will store toxicological contexts including the study design details, treatment protocols, animal characteristics and conventional toxicological endpoints such as histopathology findings and clinical chemistry measures. All of these data types can be integrated in a seamless fashion to enable data query and analysis in a biologically meaningful manner. Results: An object model, the SysBio-OM (Xirasagar et al., 2004) has been designed to facilitate the integration of microarray gene expression, proteomics and metabolomics data in the CEBS database system. We now report SysTox-OM as an open source systems toxicology model designed to integrate toxicological context into gene expression experiments. The SysTox-OM model is comprehensive and leverages other open source efforts, namely, the Standard for Exchange of Nonclinical Data ( which is a data standard for capturing toxicological information for animal studies and Clinical Data Interchange Standards Consortium ( that serves as a standard for the exchange of clinical data. Such standardization increases the accuracy of data mining, interpretation and exchange. The open source SysTox-OM model, which can be implemented on various software platforms, is presented here.

Download full-text


Available from: Alex Merrick
  • Source
    • "The chemical effects in biological systems (CEBS) database started off by making the expression profiles for toxicants studied at the NCT, publicly available, but then extended the system to be a repository for any toxicogenomics studies (Waters et al., 2008). The hallmark of CEBS is that the data from toxicogenomics experiments are curated, stored in the context of the study design, and integrated with other omics data or ancillary toxicological data (Fostel et al., 2005; Xirasagar et al., 2006). The National Toxicology Program at the NIEHS has acquired DrugMatrix, a toxicogenomics reference database and informatics system along with its companion toxicogenomics analysis suite resource ToxFX with the goal of making these resources freely available to public and ultimately facilitated the integration of toxicogenomics into hazard characterization (Scott Auerbach, personal communication). "
    [Show abstract] [Hide abstract]
    ABSTRACT: As one reflects back through the past 50 years of scientific research, a significant accomplishment was the advance into the genomic era. Basic research scientists have uncovered the genetic code and the foundation of the most fundamental building blocks for the molecular activity that supports biological structure and function. Accompanying these structural and functional discoveries is the advance of techniques and technologies to probe molecular events, in time, across environmental and chemical exposures, within individuals, and across species. The field of toxicology has kept pace with advances in molecular study, and the past 50 years recognizes significant growth and explosive understanding of the impact of the compounds and environment to basic cellular and molecular machinery. The advancement of molecular techniques applied in a whole-genomic capacity to the study of toxicant effects, toxicogenomics, is no doubt a significant milestone for toxicological research. Toxicogenomics has also provided an avenue for advancing a joining of multidisciplinary sciences including engineering and informatics in traditional toxicological research. This review will cover the evolution of the field of toxicogenomics in the context of informatics integration its current promise, and limitations.
    Full-text · Article · Mar 2011 · Toxicological Sciences
  • Source
    • "Great effort is going into building databases with the future intent to integrate different data types such as conventional clinical chemistry (ClinChem) and omics. Many of these initiatives exist within toxicology (Fostel et al., 2005; Mattes et al., 2004; Rhodes et al., 2004; Xirasagar et al., 2006). Other groups have presented integration methods of expression and clinical chemistry in different areas of biology, such as virus research (Baskin et al., 2004), toxicology (Boverhof et al., 2005), and cancer (Rhodes and Chinnaiyan, 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A large number of databases are currently being implemented within toxicology aiming to integrate diverse biological data, such as clinical chemistry, expression, and other types of data. However, for these endeavors to be successful, tools for integration, visualization, and interpretation are needed. This paper presents a method for data integration using a hierarchical model based on either principal component analysis or partial least squares discriminant analysis of clinical chemistry, expression, and nuclear magnetic resonance data using a toxicological study as case. The study includes the three toxicants alpha-naphthyl-isothiocyanate, dimethylnitrosamine, and N-methylformamide administered to rats. Improved predictive ability of the different classes is seen, suggesting that this approach is a suitable method for data integration and visualization of biological data. Furthermore, the method allows for correlation of biological parameters between the different data types, which could lead to an improvement in biological interpretation.
    Full-text · Article · May 2008 · Toxicological Sciences
  • Source
    • "SysTox-OM is a more specific application that models changes to the genome, proteome, and metabolome following introduction of a toxicant. Furthermore, it incorporates conventional toxicology information – clinical chemistry, hematology, observations and histopathology – making it possible to evaluate the changes to the phenome across multiple time points and to target specific tissues for analysis (Xirasagar et al. 2006). For example, a user could identify a single phenotype of toxicity, identify all the drugs that are known to result in it, and compare gene and protein expression profiles in the kidney following administration of each drug to look for a common pathway, mechanism, or biomarker. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Reliable biomarkers of toxicity are necessary both for the safe conduct of pre-clinical and clinical trials, and are increasingly needed for accurate clinical evaluation of treatment regimens with the potential to cause tissue injury. Recent advances in technology have added several new tools to the biomarker screening toolkit and improved the throughput of existing quantitative assays. Genomics, proteomics, and metabolomics have provided a wealth of data in the search for predictive, specific biomarkers. Multiplexed ELISA-based assay systems, silicon nanowire arrays, and patterned paper present unique abilities for fast, efficient sample analysis over a broad dynamic range. Powerful integrative systems biology software and growing open-source data repositories offer new ways to share, reduce, and analyze data from multiple sources. Novel technologies reviewed here have the potential to significantly reduce assay time and cost and improve the sensitivity of screening methods for candidate biomarkers of toxicity.
    Full-text · Article · Apr 2008 · Toxicology
Show more